All Stories

  1. Diagnosis and management of subjects with mild cognitive impairment in clinical practice: an Italian delphi consensus study
  2. The Use of Non-Invasive Brain Stimulation Techniques in Subjects with Parkinson’s Disease and Mild Cognitive Impairment: A Systematic Review
  3. Promising biomarkers for mild cognitive impairment and Alzheimer’s disease: Levels of soluble endothelial glycocalyx products
  4. Transcranial Random Noise Stimulation over the Dorsolateral Prefrontal Cortex in Patients with Parkinson’s Disease and Mild Cognitive Impairment: A Pilot Study
  5. Rituximab in stiff-person syndrome with glutamic acid decarboxylase 65 autoantibody: a systematic review
  6. TREM 2 in Parkinson’s Disease: A Promising Candidate Gene for Disease Susceptibility and Progression
  7. Telecoaching and Migraine: Digital Approach to Physical Activity in Migraine Management. A Scoping Review
  8. The Impact of COVID-19 on Migraine: The Patients’ Perspective
  9. Syndecans in Alzheimer’s disease: pathogenetic mechanisms and potential therapeutic targets
  10. Effectiveness and Safety of Mycophenolate Mophetil in Myasthenia Gravis: A Real-Life Multicenter Experience
  11. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
  12. Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
  13. Persistent Cognitive Dysfunction in a Non-Hospitalized COVID-19 Long-Hauler Patient Responding to Cognitive Rehabilitation and Citicoline Treatment
  14. Sex and gender differences in Alzheimer’s disease, Parkinson’s disease, and Amyotrophic Lateral Sclerosis: A narrative review
  15. New-onset headache following COVID-19: An Italian multicentre case series
  16. Internal carotid artery dissection in a patient with hemophilia A: a case report and literature review
  17. Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis
  18. Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
  19. Sound-Induced Flash Illusions Support Cortex Hyperexcitability in Fibromyalgia
  20. From Small Peptides to Large Proteins against Alzheimer’sDisease
  21. Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
  22. Hands–feet wireless devices: Test–retest reliability and discriminant validity of motor measures in Parkinson's disease telemonitoring
  23. Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project
  24. Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabùt Aging Project
  25. Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study
  26. Imaging of Substantia Nigra in Parkinson’s Disease: A Narrative Review
  27. Cognitive impairment and levodopa induced dyskinesia in Parkinson’s disease: a longitudinal study from the PACOS cohort
  28. Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study
  29. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study
  30. Serum alkaline phosphatase is elevated and inversely correlated with cognitive functions in subjective cognitive decline: results from the ReGAl 2.0 project
  31. Cardiovascular autonomic function and MCI in Parkinson's disease
  32. Electrocortical networks in Parkinson's disease patients with Mild Cognitive Impairment. The PaCoS study
  33. Objective assessment of blinking and facial expressions in Parkinson’s disease using a vertical electro-oculogram and facial surface electromyography
  34. Visuospatial learning is fostered in migraine: evidence by a neuropsychological study
  35. Mild Behavioral Impairment in Parkinson’s Disease: Data from the Parkinson’s Disease Cognitive Impairment Study (PACOS)
  36. Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
  37. Comment on “Sleep disturbances and later cognitive status: a multi-centre study”
  38. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI)
  39. Frequency and Correlates of Subjective Memory Complaints in Parkinson’s Disease with and without Mild Cognitive Impairment: Data from the Parkinson’s Disease Cognitive Impairment Study
  40. Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)
  41. Dietary Supplements as Surrogate of Mediterranean Diet in Healthy Smoking Subjects
  42. Ageing: from inflammation to cancer
  43. Genetic epidemiology of autosomal recessive hypercholesterolemia in Sicily: Identification by next-generation sequencing of a new kindred
  44. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design
  45. β-glucans: ex vivo inflammatory and oxidative stress results after pasta intake
  46. FragClust and TestClust, two informatics tools for chemical structure hierarchical clustering analysis applied to lipidomics. The example of Alzheimer's disease
  47. Isolated, subtle, neurological abnormalities in neurologically and cognitively healthy aging subjects
  48. Double Negative (IgG+IgD−CD27−) B Cells are Increased in a Cohort of Moderate-Severe Alzheimer's Disease Patients and Show a Pro-Inflammatory Trafficking Receptor Phenotype
  49. Lymphocytic Mitochondrial Aconitase Activity is Reduced in Alzheimer's Disease and Mild Cognitive Impairment
  50. Alzheimer’s disease and infections, where we stand and where we go
  51. Double negative (CD19+IgG+IgD−CD27−) B lymphocytes: A new insight from telomerase in healthy elderly, in centenarian offspring and in Alzheimer's disease patients
  52. SHIP2: A “NEW” Insulin Pathway Target for Aging Research
  53. The neuropsychiatric profile of Parkinson’s disease subjects with and without mild cognitive impairment
  54. Can Alzheimer Disease Be a Form of Type 3 Diabetes?
  55. Mediterranean Diet and Longevity in Sicily: Survey in a Sicani Mountains Population
  56. Prevalence and Profile of Mild Cognitive Impairment in Parkinson’s Disease
  57. Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily
  58. The symptom of low mood in the prodromal stage of mild cognitive impairment and dementia: a cohort study of a community dwelling elderly population
  59. Validation Study of the Italian Addenbrooke’s Cognitive Examination Revised in a Young-Old and Old-Old Population
  60. Cognitive Performance in Elderly Patients Undergoing Carotid Endarterectomy or Carotid Artery Stenting: A Twelve-Month Follow-Up Study
  61. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
  62. A Systematic Review of Neuropsychiatric Symptoms in Mild Cognitive Impairment
  63. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types
  64. Association between plasma lipid levels and migraine in subjects aged ≥50 years: preliminary data from the Zabùt Aging Project
  65. Comorbidity between depressive symptoms and migraine: preliminary data from the Zabút Aging Project
  66. Occurrence of cognitive impairment and dementia in the community: A 9-year-long prospective study
  67. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: Two case reports
  68. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project
  69. Migraine Mediates the Influence of C677T MTHFR Genotypes on Ischemic Stroke Risk With a Stroke-Subtype Effect
  70. Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease
  71. Interictal Executive Dysfunction in Migraineurs Without Aura: Relationship With Duration and Intensity of Attacks
  72. Predictors of progression from mild cognitive impairment to Alzheimer disease
  73. Heterogeneity in Risk Factors for Cognitive Impairment, No Dementia: Population-Based Longitudinal Study From the Kungsholmen Project
  74. Vascular Risk Factors in Mild Cognitive Impairment Subtypes
  75. Prognosis of migraine headaches in adolescents: A 10-year follow-up study
  76. Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases
  77. Association between apolipoprotein E e4 allele and apathy in probable Alzheimer's disease.
  78. Erratum
  79. Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson’s disease patients
  80. Cognitive impairment in Behçet's disease patients without overt neurological involvement
  81. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction
  82. Corrigendum to “Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function”
  83. [3H]-DA release evoked by low pH medium and internal H+ accumulation in rat hypothalamic synaptosomes: involvement of calcium ions
  84. Effects of 8-OH-DPAT on open field performance of young and aged rats prenatally exposed to diazepam: a tool to reveal 5-HT1A receptor function
  85. No association between Glu298Asp endothelial nitric oxide synthase polymorphism and Italian sporadic Alzheimer's disease
  86. Prevalence of headache in patients with Behcet's disease without overt neurological involvement
  87. Enalapril Prophylaxis for Migraine With Aura
  88. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease
  89. Migraine Headaches in Adolescents: A Five-Year Follow-Up Study
  90. Red Ear Syndrome and Migraine: Report of Eight Cases
  91. Erythematous maculopapular eruption due to rivastigmine therapy
  92. Intracerebral haemorrhage associated with sildenafil citrate
  93. Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations
  94. Cognitive deficits in beta-thalassemia major